160 related articles for article (PubMed ID: 29677533)
1. Proresolving protein Annexin A1: The role in type 2 diabetes mellitus and obesity.
Pietrani NT; Ferreira CN; Rodrigues KF; Perucci LO; Carneiro FS; Bosco AA; Oliveira MC; Pereira SS; Teixeira AL; Alvarez-Leite JI; Ferreira AV; Sousa LP; Gomes KB
Biomed Pharmacother; 2018 Jul; 103():482-489. PubMed ID: 29677533
[TBL] [Abstract][Full Text] [Related]
2. Increased adiposity in annexin A1-deficient mice.
Akasheh RT; Pini M; Pang J; Fantuzzi G
PLoS One; 2013; 8(12):e82608. PubMed ID: 24312665
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of plasma annexin A1 in human obesity.
Kosicka A; Cunliffe AD; Mackenzie R; Zariwala MG; Perretti M; Flower RJ; Renshaw D
FASEB J; 2013 Jan; 27(1):368-78. PubMed ID: 23038751
[TBL] [Abstract][Full Text] [Related]
4. Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes.
Purvis GSD; Chiazza F; Chen J; Azevedo-Loiola R; Martin L; Kusters DHM; Reutelingsperger C; Fountoulakis N; Gnudi L; Yaqoob MM; Collino M; Thiemermann C; Solito E
Diabetologia; 2018 Feb; 61(2):482-495. PubMed ID: 29085990
[TBL] [Abstract][Full Text] [Related]
5. Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl peptide receptor 2/lipoxin A4 receptor.
Dalli J; Consalvo AP; Ray V; Di Filippo C; D'Amico M; Mehta N; Perretti M
J Immunol; 2013 Jun; 190(12):6478-87. PubMed ID: 23686496
[TBL] [Abstract][Full Text] [Related]
6. Identification of AnnexinA1 as an Endogenous Regulator of RhoA, and Its Role in the Pathophysiology and Experimental Therapy of Type-2 Diabetes.
Purvis GSD; Collino M; Loiola RA; Baragetti A; Chiazza F; Brovelli M; Sheikh MH; Collotta D; Cento A; Mastrocola R; Aragno M; Cutrin JC; Reutelingsperger C; Grigore L; Catapano AL; Yaqoob MM; Norata GD; Solito E; Thiemermann C
Front Immunol; 2019; 10():571. PubMed ID: 30972066
[TBL] [Abstract][Full Text] [Related]
7. Annexin A1 and specialized proresolving lipid mediators: promoting resolution as a therapeutic strategy in human inflammatory diseases.
Perucci LO; Sugimoto MA; Gomes KB; Dusse LM; Teixeira MM; Sousa LP
Expert Opin Ther Targets; 2017 Sep; 21(9):879-896. PubMed ID: 28786708
[TBL] [Abstract][Full Text] [Related]
8. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
[TBL] [Abstract][Full Text] [Related]
9. Annexin A1 Is Increased in the Plasma of Preeclamptic Women.
Perucci LO; Carneiro FS; Ferreira CN; Sugimoto MA; Soriani FM; Martins GG; Lima KM; Guimarães FL; Teixeira AL; Dusse LM; Gomes KB; Sousa LP
PLoS One; 2015; 10(9):e0138475. PubMed ID: 26398190
[TBL] [Abstract][Full Text] [Related]
10. Annexin A1 promotes timely resolution of inflammation in murine gout.
Galvão I; Vago JP; Barroso LC; Tavares LP; Queiroz-Junior CM; Costa VV; Carneiro FS; Ferreira TP; Silva PM; Amaral FA; Sousa LP; Teixeira MM
Eur J Immunol; 2017 Mar; 47(3):585-596. PubMed ID: 27995621
[TBL] [Abstract][Full Text] [Related]
11. Proresolving Actions of Synthetic and Natural Protease Inhibitors Are Mediated by Annexin A1.
Vago JP; Tavares LP; Sugimoto MA; Lima GL; Galvão I; de Caux TR; Lima KM; Ribeiro AL; Carneiro FS; Nunes FF; Pinho V; Perretti M; Teixeira MM; Sousa LP
J Immunol; 2016 Feb; 196(4):1922-32. PubMed ID: 26800869
[TBL] [Abstract][Full Text] [Related]
12. Annexin A1 in blood mononuclear cells from patients with coronary artery disease: Its association with inflammatory status and glucocorticoid sensitivity.
Bergström I; Lundberg AK; Jönsson S; Särndahl E; Ernerudh J; Jonasson L
PLoS One; 2017; 12(3):e0174177. PubMed ID: 28329022
[TBL] [Abstract][Full Text] [Related]
13. Elevation of inactive cleaved annexin A1 in the neocortex is associated with amyloid, inflammatory and apoptotic markers in neurodegenerative dementias.
Chua XY; Chong JR; Cheng AL; Lee JH; Ballard C; Aarsland D; Francis PT; Lai MKP
Neurochem Int; 2022 Jan; 152():105251. PubMed ID: 34861326
[TBL] [Abstract][Full Text] [Related]
14. Gene deletion reveals roles for annexin A1 in the regulation of lipolysis and IL-6 release in epididymal adipose tissue.
Warne JP; John CD; Christian HC; Morris JF; Flower RJ; Sugden D; Solito E; Gillies GE; Buckingham JC
Am J Physiol Endocrinol Metab; 2006 Dec; 291(6):E1264-73. PubMed ID: 16835395
[TBL] [Abstract][Full Text] [Related]
15. [Expression of omentin in adipose tissues in obese and type 2 diabetic patients].
Cai RC; Wei L; DI JZ; Yu HY; Bao YQ; Jia WP
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(6):381-4. PubMed ID: 19567114
[TBL] [Abstract][Full Text] [Related]
16. Inflammation and cancer: role of annexin A1 and FPR2/ALX in proliferation and metastasis in human laryngeal squamous cell carcinoma.
Gastardelo TS; Cunha BR; Raposo LS; Maniglia JV; Cury PM; Lisoni FC; Tajara EH; Oliani SM
PLoS One; 2014; 9(12):e111317. PubMed ID: 25490767
[TBL] [Abstract][Full Text] [Related]
17. Control of expression and activity of peroxisome proliferated-activated receptor γ by Annexin A1 on microglia during efferocytosis.
da Rocha GHO; Loiola RA; Pantaleão LDN; Reutelingsperger C; Solito E; Farsky SHP
Cell Biochem Funct; 2019 Oct; 37(7):560-568. PubMed ID: 31479167
[TBL] [Abstract][Full Text] [Related]
18. The anti-inflammatory Annexin A1 induces the clearance and degradation of the amyloid-β peptide.
Ries M; Loiola R; Shah UN; Gentleman SM; Solito E; Sastre M
J Neuroinflammation; 2016 Sep; 13(1):234. PubMed ID: 27590054
[TBL] [Abstract][Full Text] [Related]
19. Expression of caveolin-1 in human adipose tissue is upregulated in obesity and obesity-associated type 2 diabetes mellitus and related to inflammation.
Catalán V; Gómez-Ambrosi J; Rodríguez A; Silva C; Rotellar F; Gil MJ; Cienfuegos JA; Salvador J; Frühbeck G
Clin Endocrinol (Oxf); 2008 Feb; 68(2):213-9. PubMed ID: 17803693
[TBL] [Abstract][Full Text] [Related]
20. Annexin A1 Is Involved in the Resolution of Inflammatory Responses during
Oliveira LG; Souza-Testasicca MC; Vago JP; Figueiredo AB; Canavaci AM; Perucci LO; Ferreira TP; Coelho EA; Gonçalves DU; Rocha MO; E Silva PM; Ferreira CN; Queiroz-Junior C; Sousa LP; Fernandes AP
J Immunol; 2017 Apr; 198(8):3227-3236. PubMed ID: 28289158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
